Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,236 results that match your search.22,236 results
  • The Federal Circuit’s decision in Sandoz v Amgen will lead to biosimilar companies looking to use PTAB proceedings more to invalidate drug patents, because it is now harder for them to bring district court actions before filing biosimilar applications
  • With new USPTO guidance on Alice v CLS impending, companies applying for patents have been caught between waiting to file to take the guidance into account and making sure they are first to file. Alan Wright assesses how prosecution has been affected since Alice
  • Michelle Lee provided details on the USPTO’s guidance on eligible subject matter in light of Alice at a Senate confirmation hearing, but Senator Grassley indicated that members of the next Congress should be given the chance to ask questions before she can be confirmed
  • The Organisation Africaine de la Propriété Intellectuelle (OAPI) became the 93rd member of the Madrid System on December 5
  • The EPO’s Administrative Council meets in Munich this week against a backdrop of strikes, protests and public letters criticising the Office
  • With the Federal Circuit last week issuing an important decision involving biosimilars in Sandoz v Amgen, Marion Webb reports on the issues at play in the coming patent war between biosimilar and innovative companies
  • A new report suggests that foreign plaintiffs in IP cases are winning at higher rates in Chinese courts than Chinese rights holders, notwithstanding long-standing concerns about bias in favour of domestic enterprises
  • Shogo Asaji has joined Jones Day’s Tokyo office as a partner
  • Our next webinar, on Thursday this week, promises to be essential for anyone who manages or advises on creating and managing a corporate IP portfolio
  • The number of petitions for inter partes review and covered business method review at the Patent Trial and Appeal Board both fell in November compared with October, but the third petition for post-grant review was filed by a cattle breeders association